Enhancer methylation dynamics contribute to cancer plasticity and patient mortality

Keyphrases

• Cancer Patients 100%
• Metastasis 100%
• Methylation Dynamics 100%
• Patient Mortality 100%
• Cancer Plasticity 100%
• Enhancer Methylation 100%
• Cancer Progression 66%
• In Cancer 66%
• Primary Tumor 66%
• Metastatic Melanoma 66%
• Role in Cancer 33%
• Methylation Pattern 33%
• Microenvironment 33%
• Gene Regulation 33%
• Cancer Cells 33%
• Melanoma 33%
• RNA Sequencing (RNA-seq) 33%
• MicroRNA 33%
• Tumor Progression 33%
• DNA Methylation (DNAm) 33%
• Epigenetics 33%
• Patient Outcomes 33%
• Patient Survival 33%
• Body Sites 33%
• Anticancer 33%
• Pre-metastatic Niche 33%
• Bone Metastasis 33%
• Differentially Methylated Regions 33%
• Gene Expression Programming 33%
• MiRNA Profile 33%
• Integrative Analysis 33%
• Promoter Methylation 33%
• Tumor Cancer 33%
• Organ System 33%
• Chromatin Architecture 33%
• Cancer Drivers 33%
• Cancer Cell Plasticity 33%
• Small RNA-seq 33%
• Aberrant Methylation 33%
• Genomic Features 33%
• Cancer Progress 33%
• Microenvironmental Cues 33%

Biochemistry, Genetics and Molecular Biology

• Dynamics 100%
• Methylation 100%
• Enhancer Region 100%
• Cancer Cell 16%
• RNA Sequencing 16%
• Gene Expression 8%
• Promoter Region 8%
• Tumor Progression 8%
• Anticancer 8%
• Epigenetics 8%
• MicroRNA 8%
• DNA Methylation 8%
• Differentially Methylated Regions 8%
• Cell Plasticity 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Primary Tumor 40%
• Cancer Growth 40%
• Metastatic Melanoma 40%
• microRNA 20%
• Tumor Growth 20%
• Melanoma 20%
• Bone Metastasis 20%